| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |